Skip to content

Net margin at other companies

Insulet logo
InsuletPODD
10.4%-7.9pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-9.2%-3.1pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-30%
Mannkind logo
MannkindMNKD
9.3%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-60.3%-17.4pp

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on trailing twelve months.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s net margin?
Embecta Corp. (EMBC) reported net margin of 10.7% in Q1 2026.
How has Embecta Corp.'s net margin changed year-over-year?
Embecta Corp.'s net margin increased by 119.5% year-over-year, from 4.9% to 10.7%.
What is the long-term trend for Embecta Corp.'s net margin?
Over 4 years (2021 to 2025), Embecta Corp.'s net margin has grown at a -29.4% compound annual growth rate (CAGR), from 35.6% to 8.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.